Reduced incidence of hyaline membrane disease in extremely premature infants following delay of delivery in mother with preterm labor: use of ritodrine and betamethasone

Data from two groups of infants (24 to 28 weeks' gestational age) excluded from a controlled trial of the use of calf lung surfactant extract for the prevention of hyaline membrane disease are reported. The two groups were excluded from the trial because the mothers had received betamethasone f...

Full description

Saved in:

Bibliographic Details
Published in:	Pediatrics (Evanston) Vol. 78; no. 5; pp. 767 - 774
Main Authors:	KWONG, M. S, EGAN, E. A
Format:	Journal Article
Language:	English
Published:	Elk Grove Village, IL American Academy of Pediatrics 01-11-1986
Subjects:	Betamethasone - therapeutic use Biological and medical sciences Female Genital system. Reproduction Humans Hyaline Membrane Disease - physiopathology Hyaline Membrane Disease - prevention & control Infant, Newborn Intermittent Positive-Pressure Ventilation Medical sciences Obstetric Labor, Premature - prevention & control Oxygen Consumption Pharmacology. Drug treatments Pregnancy Respiratory Distress Syndrome, Newborn - etiology Ritodrine - therapeutic use Sex Factors Time Factors Twins Human Chemotherapy Pregnancy disorders Threatened premature delivery Hyaline membrane Betamethasone Tocolytic Maternal treatment
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!